About Eatris
Eatris: Revolutionizing the Clinical Phase of Drug Development
Eatris is a leading European research infrastructure that provides cutting-edge solutions to accelerate drug development. With over 80 top-tier academic centers across Europe, Eatris is equipped to ease the road to the clinical phase and revolutionize the way drugs are developed.
At Eatris, we understand that drug development is a complex and time-consuming process. It involves multiple stages, including discovery, preclinical testing, clinical trials, and regulatory approval. Each stage requires significant investment in terms of time and resources. However, with our expertise in translational research and state-of-the-art facilities, we can help you navigate this process more efficiently.
Our team comprises some of the most talented scientists in Europe who specialize in various fields such as immunology, oncology, infectious diseases, neuroscience among others. They work collaboratively with industry partners to develop innovative therapies that address unmet medical needs.
We offer a range of services that cover all aspects of drug development from target identification to clinical trials. Our services include:
1) Target validation: We use advanced technologies such as genomics and proteomics to identify potential targets for drug development.
2) Lead optimization: We optimize lead compounds using medicinal chemistry techniques to improve their efficacy and safety profiles.
3) Preclinical testing: We conduct rigorous preclinical studies using animal models to evaluate safety and efficacy before moving on to human trials.
4) Clinical trial design: We design clinical trials based on our extensive knowledge of regulatory requirements and best practices for trial design.
5) Regulatory support: We provide expert guidance on regulatory affairs throughout the drug development process from IND/CTA filing through marketing authorization application (MAA).
Our facilities are equipped with state-of-the-art equipment for high-throughput screening assays (HTS), imaging technologies such as MRI/PET/CT scans among others which enable us to deliver high-quality results within tight timelines while maintaining strict quality control standards.
We have a proven track record of success in drug development, with several drugs developed through our infrastructure currently in clinical trials or on the market. Our partnerships with industry leaders such as Pfizer, Roche, and Novartis demonstrate our commitment to delivering innovative solutions that meet the needs of our clients.
In conclusion, Eatris is a leading European research infrastructure that provides cutting-edge solutions to accelerate drug development. With over 80 top-tier academic centers across Europe and a team of talented scientists specializing in various fields, we are equipped to ease the road to the clinical phase and revolutionize the way drugs are developed. Our range of services covers all aspects of drug development from target identification to clinical trials, and we have a proven track record of success in delivering innovative solutions that meet the needs of our clients. Contact us today to learn more about how we can help you accelerate your drug development program.